Genomictree Inc. (228760) — Capital Reinvestment Ratio
Latest as of December 2022:
0.43x
Genomictree Inc. (228760) has a Capital Reinvestment Ratio of 0.43x as of December 2022, meaning it reinvests 0% of its operating cash flow (₩4.29 Billion) in capital expenditures (₩1.82 Billion). See free cash flow generation of Genomictree Inc. to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.43x
Capex / Operating Cash Flow
Operating Cash Flow
₩4.29 Billion
KRW
Capital Expenditures
₩1.82 Billion
KRW
Data as of
Dec 2022
Most recent filing
Genomictree Inc. Capital Reinvestment Ratio (2022–2022)
This chart tracks Genomictree Inc.'s Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Genomictree Inc. (2022–2022)
Year-by-year Capital Reinvestment Ratio for Genomictree Inc. from 2022 to 2022. For live market cap and broader valuation context, see market cap of Genomictree Inc..
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.43x | ₩4.29 Billion | ₩1.82 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow